Poland
· Delayed Price · Currency is PLN Medicofarma Biotech Statistics
Total Valuation
WSE:MDB has a market cap or net worth of PLN 19.44 million. The enterprise value is 21.97 million.
| Market Cap | 19.44M |
| Enterprise Value | 21.97M |
Important Dates
The last earnings date was Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
WSE:MDB has 67.98 million shares outstanding.
| Current Share Class | 67.98M |
| Shares Outstanding | 67.98M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 10.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.87 |
| PB Ratio | 2.83 |
| P/TBV Ratio | 2.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.55 |
| EV / Sales | 17.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85
| Current Ratio | 0.85 |
| Quick Ratio | 0.85 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.55 |
Financial Efficiency
Return on equity (ROE) is -28.67% and return on invested capital (ROIC) is -14.86%.
| Return on Equity (ROE) | -28.67% |
| Return on Assets (ROA) | -8.74% |
| Return on Invested Capital (ROIC) | -14.86% |
| Return on Capital Employed (ROCE) | -20.29% |
| Revenue Per Employee | 61,243 |
| Profits Per Employee | -115,029 |
| Employee Count | 20 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 768.33 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.53% in the last 52 weeks. The beta is 3.76, so WSE:MDB's price volatility has been higher than the market average.
| Beta (5Y) | 3.76 |
| 52-Week Price Change | -62.53% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 0.41 |
| Relative Strength Index (RSI) | 60.23 |
| Average Volume (20 Days) | 27,416 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WSE:MDB had revenue of PLN 1.22 million and -2.30 million in losses. Loss per share was -0.03.
| Revenue | 1.22M |
| Gross Profit | -258,014 |
| Operating Income | -2.07M |
| Pretax Income | -2.32M |
| Net Income | -2.30M |
| EBITDA | -525,927 |
| EBIT | -2.07M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 6,239 in cash and n/a in debt, giving a net cash position of 6,239 or 0.00 per share.
| Cash & Cash Equivalents | 6,239 |
| Total Debt | n/a |
| Net Cash | 6,239 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 6.87M |
| Book Value Per Share | 0.10 |
| Working Capital | -675,035 |
Cash Flow
| Operating Cash Flow | -1.02M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -21.06%, with operating and profit margins of -169.34% and -187.82%.
| Gross Margin | -21.06% |
| Operating Margin | -169.34% |
| Pretax Margin | -189.68% |
| Profit Margin | -187.82% |
| EBITDA Margin | -42.94% |
| EBIT Margin | -169.34% |
| FCF Margin | n/a |
Dividends & Yields
WSE:MDB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -11.83% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 8, 2011. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 8, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
WSE:MDB has an Altman Z-Score of 2.34. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.34 |
| Piotroski F-Score | n/a |